Stollings, J. L., Koo, G., Lindsell, C. J., Dear, M. L., McCoy, A., Rice, T. W., … Vanderbilt Learning Healthcare System Investigators. (2023). Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit. J Allergy Clin Immunol Pract, 11(2), 632–635. https://doi.org/10.1016/j.jaip.2022.08.043

Stollings, Joanna L., Grace Koo, Christopher J. Lindsell, Mary Lynn Dear, Allison McCoy, Todd W. Rice, Elizabeth J. Phillips, Cosby A. Stone, and Vanderbilt Learning Healthcare System Investigators. “Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.” J Allergy Clin Immunol Pract 11, no. 2 (February 2023): 632–35. https://doi.org/10.1016/j.jaip.2022.08.043.

Stollings JL, Koo G, Lindsell CJ, Dear ML, McCoy A, Rice TW, et al. Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit. J Allergy Clin Immunol Pract. 2023 Feb;11(2):632–5.

Stollings, Joanna L., et al. “Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit.” J Allergy Clin Immunol Pract, vol. 11, no. 2, Feb. 2023, pp. 632–35. Pubmed, doi:10.1016/j.jaip.2022.08.043.

Stollings JL, Koo G, Lindsell CJ, Dear ML, McCoy A, Rice TW, Phillips EJ, Stone CA, Vanderbilt Learning Healthcare System Investigators. Risk-stratified management to remove low-risk penicillin allergy labels in the patients with COVID-19 in the intensive care unit. J Allergy Clin Immunol Pract. 2023 Feb;11(2):632–635.